PREVALENCE AND FACTORS ASSOCIATED WITH NON-ADHERENCE TO ANTIRETROVIRAL THERAPY IN HIV PATIENTS AT KIBUNGO REFERRAL HOSPITAL, IN RWANDA.
Authors
Mr Phocas Mukezamfura Niyonsenga
Dr Amos Habimana PhD
Dr Nsanzabera Charles
Publication Details
Article Details
Article Metrics
Abstract
Background:
It has been demonstrated that antiretroviral therapy improves health and lengthens the life of HIV positive individuals. For those living with HIV, attaining optimal adherence is turning out to be the largest obstacle. The purpose of this research was to determine how often antiretroviral therapy non-adherence is among HIV patients who visit Rwanda's Kibungo Referral Hospital.
Methods:
This study utilized a quantitative, cross-sectional design. Data collection was conducted from March 25thtoApril 30, 2024, with a sample size of 396 HIV patients on ART at Kibungo Referral Hospital. Inclusion criteria included patients aged 18 years and older who had been on ART for six months, while exclusion criteria included lack of consent and hospitalized patients. A structured questionnaire was used. The Fisher exact test and logistic regression were employed to analyze associations, with significance set at p < 0.05 and 95% CI.
Results:
The findings showed that the overall non-adherence rate to ART was 13% while the adherence rate was 87%. Also, patients without tertiary education are significantly more likely to be non-adherent to ART compared to those with tertiary education (AoR: 8.232, 95% CI: 4.124-17.217, P-value: <0.001). Patients who experience stigma are more likely to be non-adherent to ART (AoR: 2.148, 95% CI: 1.032-6.689, P-value: 0.015). Patients who perceive ART as ineffective are significantly more likely to be non-adherent (AoR: 9.333, 95% CI: 2.108-20.638, P-value: <0.001.
Conclusion:
The study found a high non-adherence rate to ART among HIV patients at Kibungo Referral Hospital, linked to factors such as younger age, lack of tertiary education, stigma, and perceived ineffectiveness of ART. It recommends implementing structured support systems and targeted interventions to improve adherence and health outcomes for these patients.
Keywords
References
1. Buh A, Deonandan R, Gomes J, Krentel A, Oladimeji O, Yaya S. Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon: A cross-sectional study. PLoS One. 2023;18: e0283991.
2. Atinga RA, Yarney L, Gavu NM. Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: A qualitative investigation. PLoS One. 2018;13: e0193995.
3. Ross J, Ingabire C, Umwiza F, Gasana J, Munyaneza A, Murenzi G, et al. How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study. PLoS One. 2021;16.
4. Ntabanganyimana D, Rugema L, Omolo J, Nsekuye O, Malamba SS. Incidence and factors associated with being lost to follow-up among people living with HIV and receiving antiretroviral therapy in Nyarugenge the central business district of Kigali city, Rwanda. PLoS One. 2022;17.
5. World Health Organization. Global update on HIV/AIDS statistics. Geneva; 2023.
6. UNAIDS. UNAIDS data 2022. Joint United Nations Programme on HIV/AIDS [Internet]. 2022. Available from: https://www.unaids.org/en/resources/documents/2023/2022_unaids_data
7. Nsanzimana S, Semakula M, Ndahindwa V, Remera E, Sebuhoro D, Uwizihiwe JP, et al. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study. BMC Infect Dis. 2019; 19:312.
8. Ministry of Health. Annual health sector performance report. Fiscal year 2021-2022. [Internet]. 2023. Available from: https://www.moh.gov.rw/index.php?eID=dumpFile&t=f&f=69777&token=c6595d564dd66742bfe4d887df3a3a7ef9652e68
9. RBC. HIV/AIDS program report: ART adherence and non-adherence in Rwanda. Kigali-Rwanda; 2023.
10. Gast A, Mathes T. Medication adherence influencing factors—an (updated) overview of systematic reviews. Syst Rev. 2019; 8:112.
11. De los Rios P, Okoli C, Punekar Y, Allan B, Muchenje M, Castellanos E, et al. Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries. Prev Med (Baltim). 2020; 139:106182.
12. Becker N, Cordeiro LS, Poudel KC, Sibiya TE, Sayer AG, Sibeko LN. Individual, household, and community level barriers to ART adherence among women in rural Eswatini. PLoS One. 2020;15: e0231952.
13. Itanga I, Ndagijimana A, Claudine Simbi CM, Ntaganira J. Opportunistic Infections and Associated Factors among HIV-Infected Adult Persons on Antiretroviral Therapy at Ruhengeri Referral Hospital, Rwanda: A cross-sectional study. Rwanda Journal of Medicine and Health Sciences. 2022; 5:323–31.
14. Hakizayezu F, Biracyaza E, Niyompano H, Umubyeyi A. The Frequency and Predictors of Unsuppressed HIV Viral Load Among People with HIV in Nyaruguru District, Rwanda. HIV/AIDS - Research and Palliative Care. 2022; Volume 14:381–95.
15. Uakarn C. Guidelines for Sample Size Calculation in Health Research. Journal of Health Statistics. 2021; 18:102–10.
16. Belayneh Y, Asmamaw Y, Amsalu M. Non-adherence to antiretroviral therapy and its determinants among HIV-infected patients in Ethiopia. Journal of HIV/AIDS & Infectious Diseases. 2017; 8:113–21.
17. Nwauche CA, Nwabueze CF, Umeh MI. ART non-adherence and associated factors among HIV-positive patients in a Nigerian hospital. African Journal of Medical Research. 2019; 12:98–104.
18. Kebede A, Mesfin A, Tadesse G. Prevalence of ART non-adherence and associated factors among HIV patients in Uganda. East African Health Journal. 2019; 6:230–8.
19. South African Bureau of Medical Epidemiology (SABME). ART adherence and non-adherence rates in South Africa: A national overview. South African Medical Journal. 2016; 106:410–5.
20. Barclay TR, Houser BL, Foulks K. ART non-adherence trends in developed regions: The US and Europe. International Journal of HIV Medicine. 2017; 13:58–67.
21. Smith L, Jones M, Diaz H. Factors influencing ART adherence among young adults. Journal of Adolescent Health. 2023; 72:124–31.
22. Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The Role of Self-Efficacy in HIV Treatment Adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES). J Behav Med. 2007; 30:359–70.
23. Parker R, Aggleton P. HIV/AIDS-related stigma and discrimination: A conceptual framework and an agenda for action. AIDS Care. 2021; 19:233-239.
24. Le PM, Nguyen PT, Nguyen H V, Bui DH, Vo SH, Nguyen N V, et al. Adherence to highly active antiretroviral therapy among people living with HIV and associated high-risk behaviours and clinical characteristics: A cross-sectional survey in Vietnam. Int J STD AIDS. 2021; 32:911–8.
25. Martin S, Bennett D, Campbell K. Shifts in smoking prevalence among young adults: A global perspective. Tob Induc Dis. 2023;21.
26. Brown MJ, Bogart LM. The role of structured treatment plans in enhancing ART adherence. Global Health Studies. 2024; 8:45-54.
27. Lewis S, Ross J, Sen D. Examining the efficacy of reminder methods in ART adherence. American Journal of Public Health, .2022; 111:1675-1683.